China Wood International Holding Co., Limited
HHKEX:18220.12
HKD
+0.00
(-3.33%)
China Wood International Holding Co., Limited
HKEX:1822
(Hong Kong Exchange)
Recent
price
0.12
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
HKD
•
in mil. unless spec.Working Capital
HKD
•
in mil. unless spec.Growth Rates
HKD
•
in mil. unless spec.Semi-annual Revenue
HKD
•
in mil. unless spec.Semi-annual Earnings Per Share
HKD
•
in mil. unless spec.Semi-annual Dividends Per Share
HKD
•
in mil. unless spec.- Similar Companies
- Business
- China Wood International Holding Co., Limited China Wood International Holding Co., Limited (1822.HK) is an investment holding company principally engaged in wood-related business, car rental services, financing services and investments, food and beverage operations, and other services; it processes and distributes furniture wood primarily made of red mahogany, sandalwood, rosewood, pine, and fir; manufactures and sells antique-style wood furniture and other wooden products; provides car rental services in the People's Republic of China (PRC); offers money lending through loans and financial investment holding; develops functional food and beverages with a focus on research and development in high-throughput fermentation for prebiotics, vitamins, amino acids, natural pigments, and flavorings, microbiota-health correlations for issues like irritable bowel syndrome and metabolic syndrome, genetic testing-based personalized nutrition, and gene-edited microbial production of food ingredients; and provides ancillary services such as public relations. The company, incorporated in 2009 in the Cayman Islands with headquarters in Hong Kong, primarily serves customers in the PRC and Hong Kong. Recent developments include the completion of a major debt restructuring in 2023 involving capital reorganisation, investor subscription of new shares, and a scheme of arrangement that discharged significant debts and disposed of certain excluded subsidiaries; a 1-for-1 rights issue in March 2025 raising approximately HK$44.6 million, of which HK$24.6 million supported general working capital and HK$20 million funded food and beverage expansion with partial utilization by late 2025; a placing of 164 million new shares in November 2025 at HK$0.10 per share raising approximately HK$16.3 million to potentially fund 30%-40% acquisition of a synthetic biology infrastructure provider specializing in strain design, fermentation, and de novo DNA synthesis for enhanced R&D efficiency, with the balance from internal resources; and ongoing negotiations for this acquisition valued at HK$18-22 million, alongside a prior subsidiary sale to Wanyi Asia Limited.